Gerresheimer First Quarter 2025 Earnings: EPS Misses Expectations

Gerresheimer (ETR:GXI) First Quarter 2025 Results

Key Financial Results

• Revenue: €520.1m (up 12% from 1Q 2024).
• Net loss: €18.0m (down by 238% from €13.0m profit in 1Q 2024).
• €0.52 loss per share (down from €0.38 profit in 1Q 2024).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gerresheimer EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 148%.

Looking ahead, revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Europe.

Performance of the market in Germany.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that Gerresheimer is showing 4 warning signs in our investment analysis and 2 of those are a bit unpleasant...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.